Literature DB >> 15317451

Functionality maps of the ATP binding site of DNA gyrase B: generation of a consensus model of ligand binding.

Martina Schechner1, Finton Sirockin, Roland H Stote, Annick P Dejaegere.   

Abstract

The Multiple Copy Simultaneous Search method (MCSS) was used to construct consensus functionality maps for functional group binding in the ATP binding site of DNA gyrase B. To account for the conformational flexibility of the protein active site, which involves small side chain fluctuations as well as large-scale loop motions, the calculations were done for three different conformations of the 24 kDa subdomain of DNA gyrase B. A postprocessing procedure that employs a continuum dielectric model to include solvent effects was used to calculate the binding free energy for every functional group. These results were ranked according to their affinity for DNA gyrase B and clustered using a new procedure based on van der Waals contacts that is better adapted for cases where multiple conformations are being considered. A total of 23 different functional groups were tested. The results gave consensus maps that indicate those functional group binding sites that are insensitive to the specific protein conformation. The maps also demonstrate that functional groups other than those found in the known ligands may bind competitively in the binding sites of known ligands. This suggests numerous scaffolds that can be used in the development of new ligands for the ATP and coumarinic binding sites in DNA gyrase B. Finally, the calculations show the existence of alternative binding sites near the known binding sites that could be targeted in the rational design for new inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317451     DOI: 10.1021/jm0311184

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Histone H3 tails containing dimethylated lysine and adjacent phosphorylated serine modifications adopt a specific conformation during mitosis and meiosis.

Authors:  Adrien Eberlin; Cédric Grauffel; Mustapha Oulad-Abdelghani; Flavie Robert; Maria-Elena Torres-Padilla; Romain Lambrot; Danièle Spehner; Lourdes Ponce-Perez; Jean-Marie Würtz; Roland H Stote; Sarah Kimmins; Patrick Schultz; Annick Dejaegere; Laszlo Tora
Journal:  Mol Cell Biol       Date:  2008-01-07       Impact factor: 4.272

Review 2.  The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design.

Authors:  Christian R Schubert; Collin M Stultz
Journal:  J Comput Aided Mol Des       Date:  2009-06-09       Impact factor: 3.686

Review 3.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

4.  Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.

Authors:  Liane Saíz-Urra; Miguel Ángel Cabrera Pérez; Matheus Froeyen
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

5.  Automated clustering of probe molecules from solvent mapping of protein surfaces: new algorithms applied to hot-spot mapping and structure-based drug design.

Authors:  Michael G Lerner; Kristin L Meagher; Heather A Carlson
Journal:  J Comput Aided Mol Des       Date:  2008-08-05       Impact factor: 3.686

6.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

7.  Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble.

Authors:  Melissa R Landon; Rommie E Amaro; Riccardo Baron; Chi Ho Ngan; David Ozonoff; J Andrew McCammon; Sandor Vajda
Journal:  Chem Biol Drug Des       Date:  2008-01-17       Impact factor: 2.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.